ARTICLE | Politics, Policy & Law
Former FDA office director Unger joins law firm
Unger, who fought approval of Sarepta’s DMD drugs, joins firm that helped secure their approval
February 23, 2022 11:52 PM UTC
Ellis Unger, who resigned from FDA in August 2021 after a 24-year career at the agency, has joined law firm Hyman, Phelps & McNamara as a principal drug regulatory expert.
Unger told BioCentury he will focus at HP&M on helping smaller companies “design clinical trials, generate and interpret data.” ...